drugset / Trial / NCT00937261

Contrasting the Brain Effects of Risperidone and Invega With Functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) Scanning

NCT00937261

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to better understand brain function and psychiatric and neurological illness when taking Invega or Risperdal. The objective is to compare the brain effects of Invega to Risperdal in patients with Schizophrenia. This comparison will be evaluated with PET imaging, fMRI, and neurological ratings and assessments.

Timeline

Start
2009-07
Primary completion
2010-07
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Paliperidone Unknown 6 mg
Subject Paliperidone Unknown 12 mg
Subject Risperidone Other / unclassified 2 mg
Subject Risperidone Other / unclassified 8 mg

Indications